Trial Profile
Insulin degludec: a flexible daily dosing regimen or the same time daily in type 2 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2011
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Dec 2011 New trial record
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.